← Leaderboards
Laurence Katznelson
Massachusetts Institute Of Technology
$6,397,956
Attributed
$6,397,956
Total exposure
15
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,397,956 · 15
By mechanism
N02$3,136,008 · 1
M01$2,926,035 · 12
R29$335,913 · 1
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Anne Klibanski$29,924,622
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHormone TherapyHuman Therapy EvaluationAcromegalyTestosteroneSomatostatinPeptide Hormone AnalogEndocrine Disorder ChemotherapyMaleHormone Regulation /Control MechanismHuman Old Age (65+)Drug Screening /EvaluationExerciseMuscle StrengthBody CompositionClinical Trial Phase IInsulinlike Growth FactorEstrogensHypogonadismProstateEndocrine PharmacologyBone MetabolismEstrogen Inhibitor
Grant awards (40)
NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE)$3,136,008
N02 · FY2025 · HL · contact PI
CLINICAL TRIAL: SOM230 IM LAR INJECTION IN PATIENTS WITH ACROMEGALY AND CARCIN$3,641
M01 · FY2008 · RR · contact PI
CONSEQUENCES OF HYPOPITUITARISM FOLLOWING TRAUMATIC BRAIN INJURY (TBI)$1,707
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: PASIREOTIDE IN PATIENTS WITH PERSISTENT OR RECURRENT CUSHING'S D$114
M01 · FY2008 · RR · contact PI
CONSEQUENCES OF HYPOPITUITARISM FOLLOWING TRAUMATIC BRAIN INJURY (TBI)$11,704
M01 · FY2007 · RR · contact PI
CONSEQUENCES OF HYPOPITUITARISM FOLLOWING TRAUMATIC BRAIN INJURY (TBI)$890
M01 · FY2006 · RR · contact PI
SOMATOSTATIN ANALOGUE LANREOTIDE IPSTYL IN PTS W/ ACROMEGALY$200,768
M01 · FY2002 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE IPSTYL IN PTS W/ ACROMEGALY$200,768
M01 · FY2002 · RR
RALOXIFENE HYDROCHLORIDE &BONE TURNOVER HORMONE LEVEL IN PROSTATE SIZE$200,768
M01 · FY2002 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE TREATMENT OF NEW PTS W/ ACROMEGALY$200,768
M01 · FY2002 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE TREATMENT OF NEW PTS W/ ACROMEGALY$200,768
M01 · FY2002 · RR
RALOXIFENE HYDROCHLORIDE &BONE TURNOVER HORMONE LEVEL IN PROSTATE SIZE$200,768
M01 · FY2002 · RR
Benefits of Testosterone on Strength in Elderly Men$200,768
M01 · FY2002 · RR
Benefits of Testosterone on Strength in Elderly Men$200,768
M01 · FY2002 · RR
BENEFITS OF TESTOSTERONE ON STRENGTH IN ELDERLY MEN$115,301
R29 · FY2002 · AG
GHRH &Testosterone Therapy on Body Composition$0
P01 · FY2002 · AG
Benefits of Testosterone on Strength in Elderly Men$200,768
M01 · FY2001 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE TREATMENT OF NEW PTS W/ ACROMEGALY$200,768
M01 · FY2001 · RR
RALOXIFENE HYDROCHLORIDE &BONE TURNOVER HORMONE LEVEL IN PROSTATE SIZE$200,768
M01 · FY2001 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE IPSTYL IN PTS W/ ACROMEGALY$200,768
M01 · FY2001 · RR
BENEFITS OF TESTOSTERONE ON STRENGTH IN ELDERLY MEN$111,936
R29 · FY2001 · AG
SOMATOSTATIN ANALOGUE LANREOTIDE IPSTYL IN PTS W/ ACROMEGALY$0
M01 · FY2001 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE (IPSTYL)--TREATMENT OF ACROMEGALY$0
M01 · FY2001 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE (IPSTYL)--TREATMENT OF ACROMEGALY$0
M01 · FY2001 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE TREATMENT OF NEW PTS W/ ACROMEGALY$0
M01 · FY2001 · RR
RALOXIFENE HYDROCHLORIDE &BONE TURNOVER HORMONE LEVEL IN PROSTATE SIZE$0
M01 · FY2001 · RR
Benefits of Testosterone on Strength in Elderly Men$0
M01 · FY2001 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE IPSTYL FOR TREATMENT OF PTS W/ ACROMEGALY$415,629
M01 · FY2000 · RR
BENEFITS OF TESTOSTERONE ON STRENGTH IN ELDERLY MEN$108,676
R29 · FY2000 · AG
SOMATOSTATIN ANALOGUE LANREOTIDE (IPSTYL)--TREATMENT OF ACROMEGALY$40,417
M01 · FY2000 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE (IPSTYL)--TREATMENT OF ACROMEGALY$40,417
M01 · FY2000 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE IPSTYL FOR TREATMENT OF PTS W/ ACROMEGALY$575
M01 · FY2000 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE TREATMENT OF NEW PTS W/ ACROMEGALY$575
M01 · FY2000 · RR
RALOXIFENE HYDROCHLORIDE &BONE TURNOVER HORMONE LEVEL IN PROSTATE SIZE$575
M01 · FY2000 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE IPSTYL IN PTS W/ ACROMEGALY$575
M01 · FY2000 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE TREATMENT OF NEW PTS W/ ACROMEGALY$0
M01 · FY2000 · RR
Benefits of Testosterone on Strength in Elderly Men$0
M01 · FY2000 · RR
SOMATOSTATIN ANALOGUE LANREOTIDE IPSTYL IN PTS W/ ACROMEGALY$0
M01 · FY2000 · RR
RALOXIFENE HYDROCHLORIDE &BONE TURNOVER HORMONE LEVEL IN PROSTATE SIZE$0
M01 · FY2000 · RR
Benefits of Testosterone on Strength in Elderly Men$0
M01 · FY2000 · RR